“In fact, we found that in vitro treatment of platelets with laropiprant prevented the inhibitory effects of PGD2 on platelet function, i.e. platelet aggregation, Ca2+ flux , P-selectin expression, activation of glycoprotein IIb/IIIa and thrombus formation.”